Isoxazolone Based Inhibitors of p38 MAP Kinases.
Journal of medicinal chemistry 2008 Mar 29; In press
Laufer S A, Margutti S S
stefan.laufer@uni-tuebingen.de.
SAR of N-alkylated isoxazolones as p38 MAP kinase inhibitors was realized. The data herein show the possibility of transferring the SAR study and evaluation from N-1-substituted imidazole to isoxazolones. Optimization of substituent was realized.
Keywords: p38 MAP Kinase MAPK

